Composition and method of using carcinoma tumor cells
US7560103B2 · kind B2 · utility
Assignee
Inventor
Key dates
| Filing date | Dec 19, 2001 |
| Grant date | Jul 14, 2009 |
| Priority date | — |
| Expiry date | Dec 19, 2021 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/892
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to compositions and methods of treating cancer. The compositions of the present invention include a composition prepared from a tumor cell which is hapten modified and syngeneic to the type of tumor to be treated. The composition has the properties, when administered with an adjuvant to a human suffering from a malignant tumor of the same type as said tumor cell, of eliciting T lymphocytes that infiltrate the tumor of said human, of eliciting an inflammatory immune response against the tumor of said human, and of eliciting a delayed-type hypersensitivity response to the tumor of said human. The methods of the present invention are directed to treating cancer comprising administering a therapeutically effective amount of a composition comprising a tumor cell.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.